Dibenzazepine Production Cost Reports

The report provides a detailed analysis essential for establishing a dibenzazepine production plant. It encompasses all critical aspects necessary for dibenzazepine production, including the cost of dibenzazepine production, dibenzazepine plant cost, dibenzazepine production costs, and the overall dibenzazepine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a dibenzazepine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Dibenzazepines are a class of tricyclic heterocyclic compounds with potential in pharmaceutical and materials applications. In the pharmaceuticals sector, derivatives such as rigid dibenzo[b,f]azepines function as potent topoisomerase II inhibitors and DNA intercalators. They have strong anti-proliferative effects across diverse cancer cell lines, while iminostilbene-based analogues target GABA-A receptors for anticonvulsant properties, as explored through in silico docking studies. Additionally, emerging materials research highlights their integration into network polymeric phthalocyanines, like NP-ZnPc and NP-CoPc, serving as degradable heterogeneous photocatalysts for efficient photodynamic processes.

Dibenzazepine’s market growth is driven by its potential in pharmaceuticals, where derivatives act as anticancer agents (e.g., topoisomerase II inhibitors) and anticonvulsants targeting GABA-A receptors. The rising demand for novel CNS and oncology therapeutics amid growing mental health and cancer prevalence boosts the market growth. Additionally, emerging materials applications, such as dibenzazepine-bridged polymeric phthalocyanines for degradable photocatalysts, provide niche growth in sustainable catalysis. Moreover, R&D investments in drug discovery and advanced materials also contribute to the market demand. Industrial dibenzazepine procurement is influenced by limited supplier availability and high production costs due to complex, multi-step synthesis requiring specialised Rh/Pd catalysts and precursors like vinylpyridines and arylboronic acids, which inflate raw material expenses amid fluctuating chemical prices.

Raw Material for Dibenzazepine Production

According to the dibenzazepine production plant project report, the various raw materials for dibenzazepine production include iminodibenzyl and nitrotoluene.

Production Process of Dibenzazepine

The extensive dibenzazepine production cost report consists of the following major industrial production process:

1. Production via the catalytic liquid-phase dehydrogenation: The production process of dibenzazepine involves the catalytic liquid-phase dehydrogenation of iminodibenzyl (10,11-dihydro-5H-dibenz[b,f]azepine). In this process, iminodibenzyl is dissolved in a high-boiling solvent like nitrotoluene or another hydrogen acceptor, followed by heating to 210-240 degree Celsius in the presence of a noble metal catalyst such as Pt/C or Pd/C (1-5 wt%). The reaction proceeds via hydrogen transfer, removing two hydrogens from the central saturated ring to form the aromatic dibenzazepine structure, achieving 77-82% isolated yields after 4-8 hours. Post-reaction, the mixture is cooled, the catalyst is filtered off, and the product is recovered via solvent distillation followed by crystallisation from ethanol or toluene.

Dibenzazepine (C14H11N) is a tricyclic heterocyclic compound having a seven-membered azepine ring fused between two benzene rings, with a molecular weight of 193.25 g/mol. It appears as a white to off-white crystalline solid and has poor water solubility but good solubility in organic solvents like DMSO, chloroform, and toluene. It has an estimated boiling point in the range of 360-380 degree Celsius under reduced pressure along with a melting point in the range of 105-110 degree Celsius range for the parent structure. It shows weak basicity due to the secondary amine (pKa ~12-13 for the conjugate acid), moderate lipophilicity (XLogP3-AA ≈ 3.5-4.0), and topological polar surface area of about 12.0 Ų, enabling reactivity in multicomponent reactions for forming derivatives used in pharmaceuticals. Its derivatives, like dibenzazepine-10,11-dione (C14H9NO2, molecular weight 223.23 g/mol), introduce carbonyl groups, increasing polarity (TPSA 46.2 Ų) and complexity (307). Its specific analogues, such as the γ-secretase inhibitor (C26H23F2N3O3, molecular weight 463.48), show melting points of 257-259 degree Celsius, density ~1.35 g/cm³, and optical activity.